{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "343", "lead_paragraph": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "pub_date": "2016-02-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mylan\u2019s New Deal May Not Be the One Shareholders Wanted", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/12/business/dealbook/mylans-new-deal-may-not-be-the-one-shareholders-wanted.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Meda AB", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "56bce0f738f0d810e6a1a1c3", "source": "The New York Times"}